Literature DB >> 22038217

Processes of apoptosis and cell proliferation in uterine myomas originating from reproductive and perimenopausal women.

Andrzej Plewka1, Danuta Plewka, Paweł Madej, Grażyna Nowaczyk, Karolina Sieron-Stoltny, Beata Jakubiec-Bartnik.   

Abstract

We studied uterine myomas originating from females of reproductive age and from females of perimenopausal age. Uterine myomas represent benign tumors of the myometrium, and they develop frequently in women of reproductive age. The frequency of uterine myomas increases with age until women reach the menopause. The study included patients with a myomatous uterus, in the reproductive age or peri-menopausal age, independently evaluating small and large myomas. Myometrial alterations in their direct vicinity were evaluated independently of the myomas. The study included evaluation of immunolocalization of two index proteins which participate in myoma cells growth control: Ki-67 nuclear antigen and caspase 3. In women of reproductive age, both in small and large myomas, elevated immunostaining of Ki-67 was noted in parallel to low levels of caspase 3 staining, which indicated the ongoing process of proliferation. In women of peri-menopausal age with small or large myomas, no Ki-67 immunostaining was detected, while staining of caspase 3 manifested low levels. Proliferation in reproductive age women myomas is higher than in the peri-menopausal age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038217     DOI: 10.5603/fhc.2011.0056

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  3 in total

1.  Symptomatic Primary Ovarian Leiomyoma in a Postmenopausal Woman: A Rare Entity.

Authors:  Mukta Meel; Deepika Hemrajani; Mukesh Kumar; Bhawna Agnani
Journal:  J Midlife Health       Date:  2020-09-29

2.  Use of chinese medicine and subsequent surgery in women with uterine fibroid: a retrospective cohort study.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

3.  Primary ovarian leiomyoma: A case report.

Authors:  Mine Islimye Taskin; Emine Ozturk; Fatma Yildirim; Necmettin Ozdemir; Umit Inceboz
Journal:  Int J Surg Case Rep       Date:  2014-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.